Berapakah harga Beta Bionics, Inc. (BBNX)

Harga Beta Bionics, Inc. (BBNX) adalah $19.81

Apakah topi pasaran Beta Bionics, Inc. (BBNX)

Cap pasaran Beta Bionics, Inc. (BBNX) adalah $891.32M

Hasil Beta Bionics, Inc. (BBNX)

Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.

Tahun	Hasil	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Hasil

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	Hasil	Perbezaan Hasil	Negara
Abbott Laboratories ABT.US	$46.59B	-	US
Stryker Corporation SYK.US	$25.84B	-	US
Medtronic plc MDT.US	$35.48B	-	IE
Boston Scientific Corporation BSX.US	$21.00B	-	US
Siemens Healthineers AG SHL.DE	-	-	DE

Syarikat

Hasil

Perbezaan Hasil

Negara